Research published in the Journal of the American Heart Association Jan. 13 has concluded administering PCSK9 inhibitors to acute MI patients ahead of ischemia can mitigate the potential negative neurological effects that come with treatment.

Measuring blood levels of vaspin could independently predict major adverse cardiac events (MACE) in patients who have suffered acute myocardial infarction (AMI), according to research published Jan. 16 in the Journal of the American Heart Association, potentially improving early risk stratification in heart attack survivors.

Sleeping less than six hours a night or experiencing poor-quality rest has been independently linked to an increased risk of subclinical multiterritory atherosclerosis, a team of Spanish researchers reported in the Journal of the American College of Cardiology Jan. 14.

A study published online in the American Journal of Epidemiology Jan. 14 suggests any physical movement, whether it’s short, long, intense or mild, counteracts the negative cardiovascular effects of sitting for long periods.

Elevated levels of cardiac troponin signal an increased risk of cardiovascular events even when the cause of that elevation is unknown, suggests a study published in the Journal of the American College of Cardiology.

A study published Jan. 8 in the Journal of the American Heart Association suggests patient adherence to statin therapy in the U.S. remains low, particularly among younger individuals, minorities and those recommended for high-intensity regimens.

The calcium-channel blocker nicardipine can effectively reverse coronary slow flow (CSF)—“an under-recognized cause of chest pain”—according to the authors of a study published online Dec. 15 in the Journal of Invasive Cardiology.

Patients with atherosclerotic cardiovascular disease (ASCVD) who struggle to pay their medical bills are at a higher risk for psychological distress, depression and a poor quality of life, according to research published in Circulation: Cardiovascular Quality and Outcomes.